China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
India’s VivaTech 2026 role gives its AI strategy a global stage as enterprises across APAC weigh regional AI partnerships, infrastructure control, and dependence on foreign chips and cloud platforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results